Quest Investment Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-254,954
Closed -$16.6M 102
2019
Q4
$16.6M Sell
254,954
-15,294
-6% -$996K 1.92% 14
2019
Q3
$17.1M Buy
270,248
+8,826
+3% +$577K 2.14% 10
2019
Q2
$17.7M Buy
261,422
+250,299
+2,250% +$16.5M 2.19% 12
2019
Q1
$723K Buy
11,123
+442
+4% +$29.4K 0.1% 80
2018
Q4
$668K Buy
10,681
+709
+7% +$49.6K 0.1% 82
2018
Q3
$770K Sell
9,972
-9,705
-49% -$733K 0.11% 87
2018
Q2
$1.39M Buy
19,677
+2,690
+16% +$190K 0.21% 75
2018
Q1
$1.28M Sell
16,987
-1,868
-10% -$148K 0.2% 80
2017
Q4
$1.35M Buy
18,855
+4,727
+33% +$359K 0.2% 77
2017
Q3
$1.15M Buy
+14,128
New +$1.08M 0.15% 79
2016
Q4
Sell
-70,097
Closed -$5.55M 103
2016
Q3
$5.55M Sell
70,097
-91,621
-57% -$7.44M 0.73% 56
2016
Q2
$13.5M Buy
161,718
+164
+0.1% +$14.6K 1.84% 25
2016
Q1
$14.8M Buy
161,554
+19,528
+14% +$1.76M 2.04% 9
2015
Q4
$14.4M Buy
142,026
+8,558
+6% +$890K 1.95% 16
2015
Q3
$13.1M Buy
133,468
+33,752
+34% +$3.75M 1.84% 10
2015
Q2
$11.7M Sell
99,716
-13,944
-12% -$1.52M 1.64% 11
2015
Q1
$11.2M Buy
113,660
+34,416
+43% +$3.49M 1.51% 20
2014
Q4
$7.47M Sell
79,244
-1,063
-1% -$110K 0.89% 41
2014
Q3
$8.55M Sell
80,307
-113,000
-58% -$11.1M 0.9% 43
2014
Q2
$16M Sell
193,307
-15,400
-7% -$1.2M 1.57% 5
2014
Q1
$14.8M Sell
208,707
-4,682
-2% -$367K 1.39% 25
2013
Q4
$16M Sell
213,389
-38,191
-15% -$2.66M 1.38% 16
2013
Q3
$15.8M Buy
251,580
+40,655
+19% +$2.43M 1.36% 19
2013
Q2
$10.8M Buy
+210,925
New +$11M 0.82% 57

Other funds holding GILD

Quest Investment Management's GILD Position: Q1 2020 in Review

Quest Investment Management sold out of Gilead Sciences (GILD) in Q1 2020, closing a stake of 254,954 shares — an estimated $16.6M sold.

Quest Investment Management first reported a position in GILD in Q2 2013 and held it in 24 quarters. The position peaked at $17.7M in Q2 2019. 1,643 funds tracked by Wall St. Rank hold GILD as of Q1 2020.

  • Quest Investment Management reported no remaining Gilead Sciences position as of Q1 2020 after selling out during the quarter.
  • Quest Investment Management sold 254,954 Gilead Sciences shares in Q1 2020, an estimated $16.6M.
  • Quest Investment Management first reported a position in Gilead Sciences in Q2 2013 and held it in 24 quarters.
  • Quest Investment Management's Gilead Sciences position peaked at $17.7M in Q2 2019.
  • 1,643 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2020.

Based on Quest Investment Management's 13F filing for Q1 2020, filed 15 May 2020.